These data are in line with two previous reports22,23 and indicate that measurement of PB WT1-mRNA expression may serve as an easy accessible marker and helpful tool to differentiate between MDS and non-MDS cytopenias. This evidence concerns the gene WT1 and myelodysplastic syndrome.